Loading clinical trials...
Loading clinical trials...
A Multicenter Phase 3 Confirmatory Trial of Biotherapy Using Cryopreserved Human Umbilical Cord (TTAX01) for Late Stage, Complex Non-healing Diabetic Foot Ulcers (AMBULATE DFU II)
Conditions
Interventions
TTAX01
Standard care
Locations
16
United States
LakeView Clinical Research
Guntersville, Alabama, United States
Banner University Medical Center Tucson
Tucson, Arizona, United States
Clemente Clinical Research
Los Angeles, California, United States
VA Northern California Health Care System
Mather, California, United States
CureCentric
Palmdale, California, United States
PIH Health
Whittier, California, United States
Start Date
November 20, 2020
Primary Completion Date
March 24, 2025
Completion Date
March 24, 2025
Last Updated
April 1, 2025
NCT07040488
NCT00777712
NCT05610865
NCT05948592
NCT05616351
NCT05921292
Lead Sponsor
BioTissue Holdings, Inc
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions